Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-making for immunization programs

Post Date

December 23rd 2015

Application Due Date

February 23rd 2016

Electronically submitted applications must be submitted no later than 11:59 p.m., Eastern Standard Time, on the listed application due date.

Funding Opportunity Number

CDC-RFA-GH16-1603

CFDA Number(s)

93.185

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

2

Eligibility Categories

Unrestricted

Funding

• Estimated Total Funding:

  $5000000

• Award Range:

  $0 - $1000000

Grant Description

The project will incorporate peer-to-peer learning through the establishment of centers of excellence (COEs) in three countries. Peers who observe evidence-based decision making, rigorous immunization program costing, innovative financing and effective legislative processes in other countries are most likely to institute those practices at home. Institutionalizing these practices will signal to vaccine manufacturers that LLMICs are prepared to negotiate and purchase their products. This will help establish a fairer and more competitive global vaccine market. As they develop, these new institutional capacities and best practices will likely be generalized to meet other public financing challenges the LLMICs face. Through such innovative project initiatives, countries will potentially be more likely to achieve the 2020 GVAP Strategic Objectives.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  Andrew Stein
  vpd4@cdc.gov
  

• Agency Mailing Address:

  Grants Policy

• Agency Email Address:

  vpd4@cdc.gov

• Location:

  Centers for Disease Control - CGH

• More Information: